Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention—MACUSTAR

BACKGROUND: There is an unmet need for treatment options in intermediate age-related macular degeneration (iAMD). However, for any new interventions to be tested in clinical trials, novel currently unavailable clinical endpoints need to be developed. Thus, the MACUSTAR study aims to develop and eval...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Trials
Hoofdauteurs: Terheyden, Jan H., Holz, Frank G., Schmitz-Valckenberg, Steffen, Lüning, Anna, Schmid, Matthias, Rubin, Gary S., Dunbar, Hannah, Tufail, Adnan, Crabb, David P., Binns, Alison, Sánchez, Clara I., Hoyng, Carel, Margaron, Philippe, Zakaria, Nadia, Durbin, Mary, Luhmann, Ulrich, Zamiri, Parisa, Cunha-Vaz, José, Martinho, Cecília, Leal, Sergio, Finger, Robert P.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2020
Onderwerpen:
Study Protocol
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7368769/
https://ncbi.nlm.nih.gov/pubmed/32682441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04595-6
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items